Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
12
×
deals
life sciences
national blog main
boston blog main
national top stories
san francisco blog main
san francisco top stories
boston top stories
fda
new york blog main
startups
boston
clinical trials
new york top stories
san diego blog main
san francisco
medical devices
raleigh-durham blog main
san diego top stories
alexion pharmaceuticals
alnylam pharmaceuticals
cancer
detroit blog main
detroit top stories
europe blog main
europe top stories
food and drug administration
indiana blog main
indiana top stories
ipo
johnson & johnson
lung cancer
m&a
medical device
new york
novartis
rna interference
sanofi
seattle blog main
What
deal
12
×
medicines
acquire
billion
cash
drug
medical
startup
adding
bio
business
company
developer
device
disease
expand
fda
help
make
new
pharma
plans
rna
tests
therapeutics
therapy
abandoning
ability
acquiring
acquisitions
adds
ago
agreed
aiming
aims
alternative
ambys
announced
approval
array
Language
unset
Current search:
xconomy.com
×
deal
×
biotech
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Stryker Adds to Trauma & Extremities Biz With $4B Wright Medical Deal
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
4 years ago
Invitae Offers $55M for Singular Bio to Expand Prenatal Test Business
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed